Literature DB >> 19164794

Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation.

Saran Shantikumar, Peter J Grant, Andrew J Catto, John M Bamford, Angela M Carter.   

Abstract

BACKGROUND AND
PURPOSE: Inflammatory biomarkers predict development of atherothrombotic events. In the present study we examined the relationships between C-reactive protein (CRP), complement C3, and long-term mortality after acute ischemic stroke.
METHODS: CRP and C3 were analyzed by in-house enzyme-linked immunosorbent assay in 394 subjects with acute ischemic stroke who survived for >30 days, followed-up for a median of 7.4 years.
RESULTS: CRP was higher in subjects who died (10.8 mg/L; 95% CI, 9.1-12.8) compared with survivors (3.8 mg/L; 95% CI, 3.1-4.7), whereas C3 was similar in both groups (P=0.26). CRP remained predictive for mortality after adjusting for conventional clinical and demographic risk factors (the adjusted hazard ratio for those with CRP in the highest compared with the lowest quartile was 2.0; 95% CI, 1.3-3.1). However, CRP was no longer independently predictive of mortality after additionally adjusting for beta-thromboglobulin or von Willebrand factor.
CONCLUSIONS: Our data suggest that the relationship between CRP and poststroke mortality may in part reflect inflammation-induced endothelial cell dysfunction and platelet activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164794     DOI: 10.1161/STROKEAHA.108.525105

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Procalcitonin Is a Stronger Predictor of Long-Term Functional Outcome and Mortality than High-Sensitivity C-Reactive Protein in Patients with Ischemic Stroke.

Authors:  Chao Wang; Li Gao; Zhi-Guo Zhang; Yu-Qian Li; Yan-Long Yang; Tao Chang; Long-Long Zheng; Xing-Ye Zhang; Ming-Hao Man; Li-Hong Li
Journal:  Mol Neurobiol       Date:  2015-02-04       Impact factor: 5.590

2.  Is a complete blood cell count useful in determining the prognosis of pulmonary embolism?

Authors:  Hadice Selimoglu Sen; Ozlem Abakay; Abdullah Cetin Tanrikulu; Cengizhan Sezgi; Mahsuk Taylan; Abdurrahman Abakay; Halide Kaya; Abdurrahman Senyigit
Journal:  Wien Klin Wochenschr       Date:  2014-03-25       Impact factor: 1.704

3.  Neuron specific enolase and c-reactive protein levels in stroke and its subtypes: correlation with degree of disability.

Authors:  Aparna Pandey; Amit Kumar Shrivastava; Kiran Saxena
Journal:  Neurochem Res       Date:  2014-05-17       Impact factor: 3.996

4.  Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis.

Authors:  Xiping Gong; Xinying Zou; Liping Liu; Yuehua Pu; Yilong Wang; Yuesong Pan; Yannie O Y Soo; Thomas W H Leung; Xingquan Zhao; Yongjun Wang; Ka Sing Wong
Journal:  Mediators Inflamm       Date:  2013-08-19       Impact factor: 4.711

5.  C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis.

Authors:  Bo Yu; Ping Yang; Xuebi Xu; Lufei Shao
Journal:  Biosci Rep       Date:  2019-02-19       Impact factor: 3.840

6.  The Relationship between Diffusion-Weighted Magnetic Resonance Imaging Lesions and 24-Hour Rhythm Holter Findings in Patients with Cryptogenic Stroke.

Authors:  Muhammet Gürdoğan; Sezgin Kehaya; Selçuk Korkmaz; Servet Altay; Uğur Özkan; Çağlar Kaya
Journal:  Medicina (Kaunas)       Date:  2019-02-04       Impact factor: 2.430

7.  Pulmonary Tuberculosis-Related Ischemic Stroke: A Retrospective Case Control Study.

Authors:  Yunfei Wei; Shiting Tang; Zhouhua Xie; Yaoqin He; Yunli Zhang; Yiju Xie; Shijian Chen; Liuyu Liu; Yayuan Liu; Zhijian Liang
Journal:  J Inflamm Res       Date:  2022-07-26

Review 8.  Monitoring biomarkers of cellular injury and death in acute brain injury.

Authors:  Sherry H-Y Chou; Claudia S Robertson
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.